Huntington’s disease (HD) is a devastating polyglutamine disorder characterized by extensive neurodegeneration and metabolic abnormalities at systemic, cellular and intracellular levels. Metabolic alterations in HD manifest as abnormal body weight, dysregulated biomolecule levels, impaired adipocyte functions, and defective energy state which exacerbate disease progression and pose acute threat to the health of challenged individuals in form of insulin resistance, cardiovascular disease, and energy crisis. To colossally mitigate disease symptoms, we tested the efficacy of curcumin in Drosophila model of HD. Curcumin is the bioactive component of turmeric (Curcuma longa Linn), well-known for its ability to modulate metabolic activities. We found that curcumin effectively managed abnormal body weight, dysregulated lipid content, and carbohydrate level in HD flies. In addition, curcumin administration lowered elevated reactive-oxygen-species levels in adult adipose tissue of diseased flies, and improved survival and locomotor function in HD flies at advanced disease stage. Altogether, these findings clearly suggest that curcumin efficiently attenuates metabolic derangements in HD flies and can prove beneficial in alleviating the complexities associated with HD.
The Huntington’s Disease Collaborative Research Group.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosome. Cell1993;
72:971–83
2.
SanbergPRFibigerHCMarkRF.Body weight and dietary factors in Huntington’s disease patients compared with matched controls. Med J Aust1981;
1:407–9
3.
GinesSSeongISFossaleEIvanovaETrettelFGusellaJFWheelerVCPersichettiFMacDonaldME.Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet2003;
12:497–508
4.
BjörkqvistMPetersénABacosKIsaacsJNorlénPGilJPopovicNSundlerFBatesGPTabriziSJBrundinPMulderH.Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington’s disease. Hum Mol Genet2006;
15:1713–21
5.
PopovicVSvetelMDjurovicMPetrovicSDoknicMPekicSMiljicDMilicNGlodicJDieguezCCasanuevaFFKosticV.Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington’s disease. Eur J Endocrinol2004;
151:451–5
6.
ChavesGÖzelRERaoNVHadiprodjoHDa CostaYTokunoZPourmandN.Metabolic and transcriptomic analysis of Huntington’s disease model reveal changes in intracellular glucose levels and related genes. Heliyon2017;
3:e00381
7.
MochelFCharlesPSeguinFBarritaultJCoussieuCPerinLLe BoucYGervaisCCarcelainGVassaultAFeingoldJRabierDDurrA.Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One2007;
2:e647
8.
UnderwoodBRBroadhurstDDunnWBEllisDIMichellAWVacherCMosedaleDEKellDBBarkerRAGraingerDJRubinszteinDC.Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain2006;
129:877–86
9.
ValenzaMRigamontiDGoffredoDZuccatoCFenuSJamotLStrandATarditiAWoodmanBRacchiMMariottiCDi DonatoSCorsiniABatesGPrussROlsonJMSipioneSTartariMCattaneoE.Dysfunction of the cholesterol biosynthetic pathway in Huntington’s disease. J Neurosci2005;
25:9932–9
10.
ChaturvediRKAdhihettyPShuklaSHennessyTCalingasanNYangLStarkovAKiaeiMCannellaMSassoneJCiammolaASquitieriFBealMF.Impaired PGC-1alpha function in muscle in Huntington’s disease. Hum Mol Genet2009;
18:3048–65
11.
AndreassenOADedeogluAStanojevicVHughesDBBrowneSELeechCAFerranteRJHabenerJFBealMFThomasMK.Huntington’s disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis2002;
11:410–24
12.
FainJNDel MarNAMeadeCAReinerAGoldowitzD.Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington’s disease mutation. Hum Mol Genet2001;
10:145–52
13.
MihmMJAmannDMSchanbacherBLAltschuldRABauerJAHoytKR.Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis2007;
25:297–308
14.
MonroyALithgowGJAlavezS.Curcumin and neurodegenerative diseases. Biofactors2013;
39:122–32
15.
HatcherHPlanalpRChoJTortiFMTortiSV.Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci2008;
65:1631–52
16.
KelseyNAWilkinsHMLinsemanDA.Neutraceutical antioxidants as novel neuroprotective agents. Molecules2010;
15:7792–814
17.
AggarwalBBSungB.Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci2009;
30:85–94
18.
AmmonHPTWahlMA.Pharmacology of Curcuma longa. Planta Med1991;
57:1–7
19.
DarveshASCarrollRTBishayeeANovotnyNAGeldenhuysWJ.Van der Schyf CJ. Curcumin and neurodegenerative diseases: a perspective. Expert Opin Investig Drugs2012;
21:1123–40
20.
DixitVPJainPJoshiSC.Hypolipidaemic effects of curcuma longa L and Nardostachys jatamansi, DC in triton-induced hyperlipidaemic rats. Indian J Physiol Pharmacol1988;
32:299–304
21.
RaoDSSekharaNCSatyanarayanaMNSrinivasanM.Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr1970;
100:1307–15
22.
FrautschySAHuWKimPMillerSAChuTHarris-WhiteMEColeGM.Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging2001;
22:993–1005
23.
YangFLimGPBegumANUbedaOJSimmonsMRAmbegaokarSSChenPPKayedRGlabeCGFrautschySAColeGM.Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem2005;
280:5892–901
24.
DeshpandePGogiaNSinghA.Exploring the efficacy of natural products in alleviating Alzheimer's disease. Neural Regen Res2019;
14:1321–9
25.
SiddiqueYHNazFJyotiS.Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic Drosophila model of Parkinson's disease. Biomed Res Int2014;
2014:1–6
26.
AnjalikaCAgrawalN.Curcumin modulates cell death and is protective in Huntington’s disease model. Sci Rep2016;
6:18736
27.
ElifaniFAmicoEPepeGCapocciLCastaldoSRosaPMontanoEPolliceAMadonnaMFilosaSCalogeroAMaglioneVCrispiSDi PardoA.Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease. Hum Mol Genet2019;
28:4012–21
28.
HickeyMAZhuCMedvedevaVLernerRPPatassiniSFranichNRMaitiPFrautschySAZeitlinSLevineMSChesseletMF.Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington’s disease. Mol Neurodegener2012;
7:1–16
29.
LimGPChuTYangFBeechWFrautschySAColeGM.The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci2001;
21:8370–7
30.
SinghMSasiPGuptaVHRaiGAmarapurkarDNWangikarPP.Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model. Hum Exp Toxicol2012;
31:788–97
31.
SuLWangYChiH.Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models. Saudi J Biol Sci2017;
24:1776–80
32.
DingLLiJSongBXiaoXZhangBQiMHuangWYangLWangZ.Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol Appl Pharmacol2016;
304:99–109
33.
WeisbergSLeibelRTortorielloDV.Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice. Nutr Diabetes2016;
6:e205
34.
MarshJLPallosJThompsonLM.Fly models of Huntington’s disease. Hum Mol Genet2003;
12:R187–R193
35.
MarshJLThompsonLM.Can flies help humans treat neurodegenerative diseases?Bioessays2004;
26:485–96
36.
AditiKShakaradMNAgrawalN.Altered lipid metabolism in Drosophila model of Huntington’s disease. Sci Rep2016;
6:1–12
37.
SinghAIrvineKD.Drosophila as a model for understanding development and disease. Dev Dyn2012;
241:1–2
38.
SinghAAgrawalN.Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease. Biochim Biophys Acta Mol Basis Dis2021;
1867:166127
39.
SteffanJSBodaiLPallosJPoelmanMMcCampbellAApostolBLKazantsevASchmidtEZhuYZGreenwaldMKurokawaRHousmanDEJacksonGRMarshJLThompsonLM.Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature2001;
413:739–43
40.
XuXGopalacharyuluPSeppänen-LaaksoTRuskeepääALAyeCCCarsonBPMoraSOresicMTelemanAA.Insulin signaling regulates fatty acid catabolism at the level of CoA activation. PLoS Genet2012;
8:e1002478
41.
ChandrashekaraKTPopliSShakaradMN.Curcumin enhances parental reproductive lifespan and progeny viability in Drosophila melanogaster. Age (Dordr)2014;
36:9702–15
42.
HandaJChandrashekaraKTKashyapKSageenaGShakaradMN.Gender based disruptive selection maintains body size polymorphism in Drosophila melanogaster. J Biosci2014;
39:609–20
43.
Owusu-AnsahEYavariABanerjeeU.A protocol for in vivo detection of reactive oxygen species. Protoc Exch2008;
10:1–8
44.
GreenMRSambrookJ.Total RNA isolation from Drosophila melanogaster. Cold Spring Harb Protoc2020;
2020:101675
45.
PringsheimTWiltshireKDayLDykemanJSteevesTJetteN.The incidence and prevalence of Huntington’s disease: a systematic review and Meta-analysis. Mov Disord2012;
27:1083–91
46.
GanigerSMalleshappaHNKrishnappaHRajashekharGRaoVRSullivanF.A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food Chem Toxicol2007;
45:64–9
47.
BegumANJonesMRLimGPMoriharaTKimPHeathDDRockCLPruittMAYangFHudspethBHuSFaullKFTeterBColeGMFrautschySA.Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther2008;
326:196–208
48.
IresonCOrrSJonesDJVerschoyleRLimCKLuoJLHowellsLPlummerSJukesRWilliamsMStewardWPGescherA.Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res2001;
61:1058–64
49.
PanMHHuangTMLinJK.Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos1999;
27:486–94
50.
SandhirRYadavAMehrotraASunkariaASinghASharmaS.Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease. Neuromolecular Med2014;
16:106–18
51.
MarshJLWalkerHTheisenHZhuYZFielderTPurcellJThompsonLM.Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet2000;
9:13–25
52.
MarshJLThompsonLM.Drosophila in the study of neurodegenerative disease. Neuron2006;
52:169–78
53.
PhomLAchumiBAloneDPMuralidharaYenisettiSC.Curcumin’s neuroprotective efficacy in Drosophila model of idiopathic Parkinson’s disease is phase specific: Implication of its therapeutic effectiveness. Rejuvenation Res2014;
17:481–9
54.
ShaoWYuZChiangYYangYChaiTFoltzWLuHFantusIGJinT.Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One2012;
7:e28784
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
